NordLayer-Black.png
NordLayer named a finalist at the SaaS Awards and Computing Security Awards 2023
September 04, 2023 12:30 ET | NordLayer
LONDON, Sept. 04, 2023 (GLOBE NEWSWIRE) -- NordLayer not only has secured its place as a finalist in the prestigious 2023 SaaS Awards program, competing in the category of Best Security Innovation...
ONL logo.jpg
ONL Therapeutics Completes Enrollment in Phase 2 Study of First-in-Class Fas-Inhibitor in Patients with Macula-Off Rhegmatogenous Retinal Detachment
August 28, 2023 07:00 ET | ONL Therapeutics
More than 135 patients recruited in four months for Phase 2 study of a single intravitreal (IVT) injection of ONL1204 Ophthalmic Solution as adjunct to standard-of-care surgery Topline data readout...
RG logo 7.png
RetinalGenix Technologies Inc. Announces the Addition of Fred Chasalow, Ph.D., to the Medical Advisory Board of DNA-GPS
August 28, 2023 06:35 ET | RetinalGeniX Technologies, Inc.
PETALUMA, Calif., Aug. 28, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX™ Technologies, Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”) today announced the addition of Fred Chasalow, Ph.D., to the...
RG logo 7.png
RetinalGeniX Technologies Inc. Granted Patent for Patient Home Monitoring and Physician Alert System for Ocular Anatomy
July 28, 2023 13:24 ET | RetinalGeniX Technologies, Inc.
PETALUMA, Calif., July 28, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX™ Technologies, Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”), this week was granted a patent for its Patient Home Monitoring...
nacuity-pharmaceuticals-inc.jpg
Nacuity Pharmaceuticals Advances Phase 1/2 Clinical Trial Evaluating NPI-002 Intravitreal Implant for the Delay of Cataract Progression
July 11, 2023 09:00 ET | Nacuity Pharmaceuticals, Inc.
New clinical site added and early safety signals observed in trial for treatment of ocular disease caused by oxidative stress First cohort is expected to achieve full enrollment by third quarter...
RG logo 7.png
RetinalGeniX Technologies, Inc. Nears Completion of Institutional Review Board for Research on DNA/GPS Program
June 26, 2023 06:15 ET | RetinalGeniX Technologies, Inc.
PETALUMA, Calif., June 26, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX™ Technologies, Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”), today previewed the completion of an Institutional Review Board...
RG logo 7.png
Retinalgenix Technologies, Inc. Expands Team to Hasten the Launch of DNA/GPS
June 07, 2023 05:35 ET | RetinalGeniX Technologies, Inc.
PETALUMA, Calif., June 07, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX™ Technologies, Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”), announced today the hiring of Owen Watson, MS. Mr. Watson’s...
NordLayer-Black.png
NordLayer launches a new and one-of-the-kind Browser Extension
May 24, 2023 10:16 ET | NordLayer
LONDON, May 24, 2023 (GLOBE NEWSWIRE) -- The NordLayer team is happy to announce that from now on, people can access their business resources via a browser extension. The extension introduces a new...
researchdrivelogo.jpg
Global Microcontroller Market Anticipated to Garner $56.3 Billion, Growing at a 11.7% CAGR in the 2022–2031 Timeframe [260-Pages] | Backed by Research Dive
May 22, 2023 09:01 ET | Research Dive
New York, USA, May 22, 2023 (GLOBE NEWSWIRE) -- Research Dive has published a new report on the global microcontroller market. According to the report, the global market is projected to surpass...
Contrive Datum Insights_Logo.jpg
The Automated Guided Vehicles Market is projected to grow from USD 2.17 billion in 2022 to USD 4.11 billion by 2030, exhibiting a CAGR of 9.6% during the forecast period.| Data By Contrive Datum Insights Pvt Ltd.
May 11, 2023 17:00 ET | Contrive Datum Insights Pvt Ltd
Farmington, May 11, 2023 (GLOBE NEWSWIRE) -- The Global Automated Guided Vehicles Market is projected to grow from USD 2.17 billion in 2022 to USD 4.11 billion by 2030, exhibiting a CAGR of 9.6%...